부품 정보
Cetylpyridinium chloride lozenges usp 1.5mg 648s
TXT
묘사:
Cetylpyridinium Chloride Lozenge
MRC:
The ingredients compounded in a pharmaceutical preparation and recognized as having therapeutic value/s/. /usually representative in the item name generic nomenclature./AKJA
Active Medicament Medicinal Strength:
1.500 milligrams cetylpyridinium chloride active ingredient
MRC:
Those features,not otherwise specified,which may be required for proper functioning of the item.CBBL
Features Provided:
Individually sealed
MRC:
Indicates the type of container/s/ or supporting device/s/ which is in direct contact with the item.CQCT
Primary Container Type:
Strip
MRC:
A numeric value of the volume,form,or dosage within each primary container.CRLK
Primary Container Content Quantity:
648.000 lozenges
MRC:
The number of primary containers within the item of supply.CSCW
Total Primary Container Quantity:
648
MRC:
An indication of the area,orifice,or tissue of the body to which the medication is administered or applied,based on the drug formulation.CSGS
Administration:
Oral
MRC:
Those unusual or unique characteristics or qualities of an item not covered in the other requirements and which are determined to be essential for identification.FEAT
Special Features:
Ea lozenge contains 0.3 pct benzyl alcohol and aromatics in a suitable base
